Table 4.
Logistic regression analysis (site of recurrence)
| Unadjusted OR# No Trastuzumab |
p Value | Adjusted OR# No Trastuzumab* |
p Value | Unadjusted OR# Trastuzumab |
p Value | Adjusted OR# Trastuzumab* |
p Value | |
|---|---|---|---|---|---|---|---|---|
| Luminal B versus HER2 | Luminal B versus HER2 | Luminal B versus HER2 | Luminal B versus HER2 | |||||
| LRR | 0.95 (0.399,2.338) |
0.907 | 1.39 (0.471,4.50) |
0.557 | 0.16 (0.04,0.51) |
<0.001 | 0.13 (0.02,0.59) |
0.018 |
| Distant | 1.22 (0.618,2.459) |
0.566 | 1.21 (0.508,2.95) |
0.660 | 0.50 (0.211,1.16) |
0.107 | 0.51 (0.17,1.44) |
0.214 |
| Bone | 3.09 (1.246,8.805) |
0.022 | 4.63 (1.53,17.50) |
0.012 | 1.05 (0.253,5.22) |
0.945 | 0.958 (0.17,5.60) |
0.960 |
| Brain | 0.49 (0.117,1.923) |
0.301 | 0.41 (0.09,1.76) |
0.231 | 0.26 (0.07,0.829) |
0.029 | 0.19 (0.03,0.85) |
0.041 |
| Lung | 1.53 (0.661,3.786) |
0.333 | 2.15 (0.78,6.688) |
0.161 | 0.26 (0.05,0.946) |
0.05 | 0.36 (0.06,1.57) |
0.198 |
| Liver | 1.44 (0.536,4.324) |
0.483 | 1.03 (0.33,3.39) |
0.958 | 1.49 (0.405,7.04) |
0.569 | 1.03 (0.22,5.64) |
0.971 |
Bold values indicate significant p value
# 95% CI
* Adjusted to stage and grade
LRR Local Regional Recurrence, DFS Disease-Free Survival, OS Overall survival